Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abidol vs Oseltamivir for Influenza-like Illness in Adults (Phase 4, China)
ChiCTR2100043928Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in influenza-like illness (ILI) comparing Abidol (umifenovir) arm with Oseltamivir arm (2 arms). Primary endpoints: Time for body temperature to drop to normal and Time to return to normal life and work. Started Dec 2020; status: recruiting.
02
Drugs
umifenoviroseltamivir
03
Conditions
influenza-like illness (ILI)
Beyond the preview
Go deeper on ChiCTR2100043928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043928.